— Richard Sear, Emilie Dubernay & Richard Dutton
In this report, explore six themes Dolon believes will impact pricing and access success for rare disease and oncology medicines in 2025.
Theme 1: Rising pricing tension
Theme 2: Protectionist Policies
Theme 3: GLP-1 Wave
Theme 4: Oncology Crowding
Theme 5: JCA “Implementation Time”
Theme 6: AI and Efficiency
